A bench headed by NGT Chairperson Justice Swatanter Kumar took on record a compliance affidavit regarding enviromental clearance to existing treatment plants in the city filed by Delhi Pollution Control Committee and asked other parties in the case to file their objections within two weeks.
"We leave open the question as to whether there should be multi-site for the bio-medical waste or there should be only one or two sites.
"In the meanwhile, we also make it clear that all the bio-medical waste plants must take environmental clearance in accordance with law," the bench said while posting the matter for next hearing on March 27.
"Scientific studies show that bio-medical waste is one of the more serious and hazardous pollutants and it can produce large number of infectious diseases which would be very harmful to the humanity at large. Their impact on public health can be very adverse and it is not only expected but is mandatory that such bio-medical waste is dealt with strictly," it had said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
